We Know Virtually Nothing About the Clinical Effects of Cannabinoids and Medical Marijuana on Alzheimer’s Disease

In this installment of “Let’s Talk,” Dr Herrmann discusses the limited research on marijuana’s effect on agitation and aggression in Alzheimer’s disease, despite widespread interest in the subject.

Technology in the Clinical Care of Depression: Moving Beyond Face-to-Face Treatment

In this installment of Let’s Talk, read about the evidence for technological interventions for depression, and how such treatment benefits patients.